Lipocine (LPCN) Misses Q3 EPS by 67c
Tweet
Share
E-mailGet Alerts LPCN Hot Sheet
Join SI Premium – FREE
Lipocine (NASDAQ: LPCN) reported Q3 EPS of ($1.27), $0.67 worse than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Lipocine (LPCN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
